Transaction in Own Shares

Summary by AI ^BETAClose X

Melrose Industries PLC has purchased a total of 85,300 ordinary shares between June 1st and June 5th, 2026, through Merrill Lynch International. The volume-weighted average price for these purchases ranged from 450.2732 pence to 471.5866 pence. Following these transactions, the company now holds 65,143,026 shares in treasury, with 1,246,332,295 ordinary shares in issue excluding treasury shares.

Disclaimer*

Melrose Industries PLC

08 June 2026


8ᵗʰ June 2026
Melrose Industries PLC
("Melrose" or the "Company")
Transaction in Own Shares

The Company announces today it has purchased the following number of its ordinary shares of £0.001 each through Merrill Lynch International ("MLI") in the period from 1ˢᵗ June 2026 to 5ᵗʰ June 2026.

Date	Venue	Volume-weighted average price (p)	Aggregated volume	Lowest price per share (pence)	Highest price per share (p)
1 June 2026	XLON	471.5866	67,000	463.5000	480.4000
2 June 2026	XLON	462.4200	6,000	458.0000	472.8000
3 June 2026	XLON	450.2732	6,100	445.5000	454.2000
4 June 2026	XLON	457.3320	6,100	453.8000	459.9000
5 June 2026	XLON	464.8937	6,100	461.5000	467.3000


The Company intends to hold the purchased shares in treasury.

Following the above transaction, the Company has 65,143,026 ordinary shares in treasury and has 1,246,332,295 ordinary shares in issue (excluding treasury shares).


Individual Transactions
In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014 as it forms part of UK law, a full breakdown of the individual trades made by the MLI on behalf of the Company as part of the buyback programme is attached to this announcement.
http://www.rns-pdf.londonstockexchange.com/rns/2798H_1-2026-6-5.pdf

For further information please contact:
Warren Fernandez Company Secretary

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END